CAM has recently gained attention as a rare but severe complication in COVID-19 patients, likely associated with the widespread use of corticosteroids, uncontrolled hyperglycemia, broad-spectrum antibiotics, and interleukin 6 inhibitors [7,21,39,40,41,42]. This evidence concerns the gene IL6 and COVID-19.